Literature DB >> 27761641

Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.

Aristide Merola1, Alberto Romagnolo2, Laura Rizzi2, Mario Giorgio Rizzone2, Maurizio Zibetti2, Michele Lanotte2, George Mandybur3, Andrew P Duker4, Alberto J Espay4, Leonardo Lopiano2.   

Abstract

To determine the clinical and demographic correlates of persistent, remitting, and new-onset impulse control behaviors (ICBs) before and after subthalamic deep brain stimulation (STN-DBS) in Parkinson's disease (PD). We compared the pre- and post-surgical prevalence of ICBs, classified as impulse control disorders (ICD), dopamine dysregulation syndrome (DDS), and punding in 150 consecutive PD STN-DBS-treated patients and determined the association with motor, cognitive, neuropsychological, and neuropsychiatric endpoints. At baseline (before STN-DBS), ICBs were associated with younger age (p = 0.045) and male gender (85 %; p = 0.001). Over an average follow-up of 4.3 ± 2.1 years of chronic STN-DBS there was an overall trend for reduction in ICBs (from 17.3 to 12.7 %; p = 0.095) with significant improvement in hypersexuality (12-8.0 %; p = 0.047), gambling (10.7-5.3 %; p = 0.033), and DDS (4.7-0 %; p < 0.001). ICB remitted in 18/26 patients (69 %) and persisted in 8/26 (31 %); the latter group was characterized by higher levodopa equivalent daily dose. Patients who developed a new-onset ICB during follow-up (n = 11/150) were characterized by younger age (p = 0.042), lower dyskinesia improvement (p ≤ 0.035), and a gender distribution with higher prevalence of women (p = 0.018). In addition, new-onset ICB was more common among patients with borderline, schizoid, and/or schizotypal traits of personality disorders; persistent ICB in those with obsessive-compulsive traits. PD-related ICBs exhibit a complex outcome after STN-DBS, with a tendency for overall reduction but with age, gender, dopaminergic therapy, and neuropsychiatric features exerting independent effects.

Entities:  

Keywords:  Electrical stimulation; Impulse control behaviors; Neurosurgery; Parkinson’s disease; Personality

Mesh:

Year:  2016        PMID: 27761641     DOI: 10.1007/s00415-016-8314-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Calculating total electrical energy delivered by deep brain stimulation systems.

Authors:  Adam M Koss; Ron L Alterman; Michele Tagliati; Jay L Shils
Journal:  Ann Neurol       Date:  2005-07       Impact factor: 10.422

3.  Punding and dyskinesias.

Authors:  Laura Silveira-Moriyama; Andrew H Evans; Regina Katzenschlager; Andrew J Lees
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

Review 4.  Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

Review 5.  Genetics of impulse control disorders in Parkinson's disease.

Authors:  Florence Cormier; Julia Muellner; Jean-Christophe Corvol
Journal:  J Neural Transm (Vienna)       Date:  2012-12-12       Impact factor: 3.575

6.  Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Authors:  Francesca Morgante; Alfonso Fasano; Monia Ginevrino; Simona Petrucci; Lucia Ricciardi; Francesco Bove; Chiara Criscuolo; Marcello Moccia; Anna De Rosa; Chiara Sorbera; Anna Rita Bentivoglio; Paolo Barone; Giuseppe De Michele; Maria Teresa Pellecchia; Enza Maria Valente
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

7.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Authors:  V Voon; K Hassan; M Zurowski; M de Souza; T Thomsen; S Fox; A E Lang; J Miyasaki
Journal:  Neurology       Date:  2006-09-06       Impact factor: 9.910

8.  Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

Authors:  Alexandre Eusebio; Tatiana Witjas; Julien Cohen; Frédérique Fluchère; Elisabeth Jouve; Jean Régis; Jean-Philippe Azulay
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-02-27       Impact factor: 10.154

9.  Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up.

Authors:  P Amami; I Dekker; S Piacentini; F Ferré; L M Romito; A Franzini; E M J Foncke; A Albanese
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-10       Impact factor: 10.154

10.  Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome.

Authors:  Sarah J Moum; Catherine C Price; Natlada Limotai; Genko Oyama; Herbert Ward; Charles Jacobson; Kelly D Foote; Michael S Okun
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

View more
  14 in total

Review 1.  New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.

Authors:  Giacomo Grassi; Giovanni Albani; Federica Terenzi; Lorenzo Razzolini; Silvia Ramat
Journal:  Neurol Sci       Date:  2021-04-14       Impact factor: 3.307

Review 2.  Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario.

Authors:  Giovanni Cossu; Mariachiara Sensi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

3.  Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's disease.

Authors:  Khaled Moussawi; Min Jae Kim; Sydney Baybayan; Myles Wood; Kelly A Mills
Journal:  Brain Stimul       Date:  2021-11-05       Impact factor: 8.955

Review 4.  Basal Forebrain Impairment: Understanding the Mnemonic Function of the Septal Region Translates in Therapeutic Advances.

Authors:  Marian Tsanov
Journal:  Front Neural Circuits       Date:  2022-05-31       Impact factor: 3.342

Review 5.  Closed Loop Deep Brain Stimulation for PTSD, Addiction, and Disorders of Affective Facial Interpretation: Review and Discussion of Potential Biomarkers and Stimulation Paradigms.

Authors:  Robert W Bina; Jean-Phillipe Langevin
Journal:  Front Neurosci       Date:  2018-05-04       Impact factor: 4.677

6.  Impulse Control Disorder in Parkinson's Disease: A Meta-Analysis of Cognitive, Affective, and Motivational Correlates.

Authors:  Alice Martini; Denise Dal Lago; Nicola M J Edelstyn; James A Grange; Stefano Tamburin
Journal:  Front Neurol       Date:  2018-08-28       Impact factor: 4.003

Review 7.  Efficacy of Invasive and Non-Invasive Brain Modulation Interventions for Addiction.

Authors:  Judy Luigjes; Rebecca Segrave; Niels de Joode; Martijn Figee; Damiaan Denys
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

Review 8.  Deep brain stimulation: current challenges and future directions.

Authors:  Andres M Lozano; Nir Lipsman; Hagai Bergman; Peter Brown; Stephan Chabardes; Jin Woo Chang; Keith Matthews; Cameron C McIntyre; Thomas E Schlaepfer; Michael Schulder; Yasin Temel; Jens Volkmann; Joachim K Krauss
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

9.  Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.

Authors:  Sandra Kurcova; Jan Bardon; Miroslav Vastik; Marketa Vecerkova; Monika Frolova; Lenka Hvizdosova; Martin Nevrly; Katerina Mensikova; Pavel Otruba; David Krahulik; Egon Kurca; Stefan Sivak; Jana Zapletalova; Petr Kanovsky
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

10.  Deep Brain Stimulation in Moroccan Patients With Parkinson's Disease: The Experience of Neurology Department of Rabat.

Authors:  Mounia Rahmani; Maria Benabdeljlil; Fouad Bellakhdar; Mustapha El Alaoui Faris; Mohamed Jiddane; Khalil El Bayad; Fatima Boutbib; Rachid Razine; Rachid Gana; Moulay R El Hassani; Nizar El Fatemi; Meryem Fikri; Siham Sanhaji; Hennou Tassine; Imane El Alaoui Balrhiti; Souad El Hadri; Najwa Ech-Cherif Kettani; Najia El Abbadi; Mourad Amor; Abdelmjid Moussaoui; Afifa Semlali; Saadia Aidi; El Hachmia Ait Benhaddou; Ali Benomar; Ahmed Bouhouche; Mohamed Yahyaoui; Abdeslam El Khamlichi; Abdessamad El Ouahabi; Rachid El Maaqili; Houyam Tibar; Yasser Arkha; Adyl Melhaoui; Abdelhamid Benazzouz; Wafa Regragui
Journal:  Front Neurol       Date:  2018-07-31       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.